Registered outcomes15

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 15 of 15

List	Outcome	Time frame
Primary	Parts 1A and 1B: Incidence and Severity of Adverse Events (AEs)	From first dose up to approximately 5 years
Primary	Part 2: Incidence and Severity of AEs	From first dose up to approximately 5 years
Primary	Parts 3A, 3B and 3C: Incidence and Severity of AEs	From first dose up to approximately 5 years
Primary	Parts 1A and 1B: Incidence of Dose-limiting Toxicities (DLTs)	From Cycle 1 Day 1 (C1D1) until C1D21 (Cycle 1 = 21 days)
Primary	Part 3A: Incidence of DLTs	From C1D1 until C1D21 (Cycle 1 = 21 days)
Primary	Parts 3B and 3C: Incidence of DLTs	From C1D1 until C1D28 (Cycle 1 = 28 days)
Primary	Parts 1A and 1B: Recommended Dose for Expansion (RDE) of RO7836748 Monotherapy	Up to approximately 5 years
Primary	Parts 3A, 3B, 3C: RDE of RO7836748 in Combination With Other Anti-Cancer Therapies	Up to approximately 5 years
Secondary	Parts 1A, 1B and 2: Plasma Concentrations of RO7836748 and its Metabolites as Monotherapy	Up to approximately 5 years
Secondary	Parts 3A, 3B and 3C: Plasma Concentrations of RO7836748 and its Metabolites in Combination With Other Anti-Cancer Therapies.	Up to approximately 5 years
Secondary	All Parts: Objective response rate (ORR)	Up to approximately 5 years
Secondary	All Parts: Duration of response (DoR)	Up to approximately 5 years
Secondary	All Parts: Disease control rate (DCR)	Up to approximately 5 years
Secondary	All Parts: Progression-free survival (PFS)	Up to approximately 5 years
Secondary	All Parts: Overall survival (OS)	Up to approximately 5 years

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07905924/registered